Predictions
Plug Power Inc.
Start price
Target price
Perf. (%)
€8.11
30.05.23
30.05.23
-
30.05.24
30.05.24
6.26%
12.06.23
12.06.23
Could be very worthwhile Investment >20% year
Capable Management
High valuation
Increased challenges to pay loans and raise capital
Verastem Inc.
Start price
Target price
Perf. (%)
€13.94
30.05.23
30.05.23
-
30.05.24
30.05.24
-19.06%
11.06.23
11.06.23
Could be very worthwhile Investment >20% year
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.24
08.06.23
08.06.23
-
08.06.24
08.06.24
-12.10%
11.06.23
11.06.23
Could be worthwhile Investment >10% per year
Martin Midstream Partners L.P.
Start price
Target price
Perf. (%)
€1.02
13.04.22
13.04.22
€1.50
-
30.05.23
30.05.23
Could be worthwhile Investment >10% per year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.79
15.05.23
15.05.23
-
15.05.24
15.05.24
-1.17%
29.05.23
29.05.23
Could be very worthwhile Investment >20% year
Akoustis Technologies Inc
Start price
Target price
Perf. (%)
€2.58
26.04.23
26.04.23
€2.40
26.04.24
26.04.24
6.98%
28.05.23
28.05.23
Higher EBIT margin than peer group
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Kulicke & Soffa Industries Inc.
Start price
Target price
Perf. (%)
€42.29
06.01.23
06.01.23
€54.00
06.01.24
06.01.24
13.27%
25.05.23
25.05.23
Could be very worthwhile Investment >20% year
Undervalued
Capable Management
Significant cyclical dependencies
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.75
22.05.22
22.05.22
-
22.05.23
22.05.23
-78.27%
22.05.23
22.05.23
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€3.19
11.06.22
11.06.22
€1.60
11.06.23
11.06.23
84.40%
19.05.23
19.05.23
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€14.42
29.08.22
29.08.22
-
29.08.23
29.08.23
-59.22%
19.05.23
19.05.23
Could be very worthwhile Investment >20% year
American Public Ed.
Start price
Target price
Perf. (%)
€13.40
18.05.22
18.05.22
€18.00
18.05.23
18.05.23
-57.09%
19.05.23
19.05.23
Could be worthwhile Investment >10% per year
Good culture
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€3.15
26.12.22
26.12.22
-
26.12.23
26.12.23
200.63%
18.05.23
18.05.23
Could be very worthwhile Investment >20% year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€3.84
17.10.22
17.10.22
-
17.10.23
17.10.23
40.63%
18.05.23
18.05.23
Risky Investment
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€2.16
20.03.23
20.03.23
-
20.03.24
20.03.24
19.03%
18.05.23
18.05.23
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€13.04
23.01.23
23.01.23
-
23.01.24
23.01.24
-3.72%
15.05.23
15.05.23
Risky Investment
Pulmatrix Inc.
Start price
Target price
Perf. (%)
€2.76
03.05.23
03.05.23
-
03.05.24
03.05.24
-9.60%
15.05.23
15.05.23
Could be very worthwhile Investment >20% year
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.12
10.05.23
10.05.23
-
10.05.24
10.05.24
9.93%
15.05.23
15.05.23
Risky Investment
Overstock.com
Start price
Target price
Perf. (%)
€28.80
14.05.22
14.05.22
-
14.05.23
14.05.23
-37.21%
15.05.23
15.05.23
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.33
12.05.23
12.05.23
-
12.05.24
12.05.24
-2.26%
14.05.23
14.05.23
Risky Investment
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€8.16
01.05.23
01.05.23
€11.00
01.05.24
01.05.24
6.50%
13.05.23
13.05.23
Fair valuation
High dividend yield expected
Small Risks for its business
Little Investments for future growth